Clinical trial
Shortening Duration of Antiarrhythmic Medication for SVT in Infants
NCT04837261 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Shortening Duration of Antiarrhythmic Medication for SVT in Infants
- Lead sponsor
- Tampere University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 15, 2021
- Completion date
- January 31, 2024
- Enrollment
- 107 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
supraventricular tachycardia